Mono Pharmacare (NSE:MONOPHARMA) COGS-to-Revenue : 0.91 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mono Pharmacare COGS-to-Revenue?

Mono Pharmacare's Cost of Goods Sold for the six months ended in Sep. 2024 was ₹794 Mil. Its Revenue for the six months ended in Sep. 2024 was ₹872 Mil.

Mono Pharmacare's COGS to Revenue for the six months ended in Sep. 2024 was 0.91.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Mono Pharmacare's Gross Margin % for the six months ended in Sep. 2024 was 8.95%.

Mono Pharmacare COGS-to-Revenue Historical Data

The historical data trend for Mono Pharmacare's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mono Pharmacare COGS-to-Revenue Chart

Mono Pharmacare Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

0.94

0.91

0.90

Mono Pharmacare Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial			0.94	0.90	0.91	0.90	0.91

Mono Pharmacare COGS-to-Revenue Calculation

Mono Pharmacare's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1106.76	/	1223.402
	=	0.90

Mono Pharmacare's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	793.576	/	871.628
	=	0.91

Mono Pharmacare (NSE:MONOPHARMA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Mono Pharmacare's Gross Margin % for the six months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	793.576 / 871.628
	=	8.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Mono Pharmacare COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mono Pharmacare's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mono Pharmacare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mono Pharmacare Ltd (NSE:MONOPHARMA) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1A, Krinkal Apartment, Opp. Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007

Website

https://www.monopharmacareltd.com

Mono Pharmacare Ltd is a distributor and supplier of a wide array of Pharmaceuticals products and medicines. The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac-Diabetic medicines, and cosmocare products.

Mono Pharmacare Headlines

No Headlines